| Schedule of Basic and Diluted Net Loss per Share Attributable to Common Stockholders |
The
following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders
(in thousands, except share and per share data):
Schedule of Basic and Diluted Net Loss per Share Attributable to Common Stockholders
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three Months Ended | | |
Six Months Ended | |
| | |
June 30, | | |
June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Net loss | |
$ | (604 | ) | |
$ | (5,324 | ) | |
$ | (5,356 | ) | |
$ | (9,527 | ) |
| Weighted average common shares outstanding, basic and diluted | |
| 12,923,710 | | |
| 9,351,557 | | |
| 12,306,944 | | |
| 9,108,091 | |
| Net loss per share, basic and diluted | |
$ | (0.05 | ) | |
$ | (0.57 | ) | |
$ | (0.44 | ) | |
$ | (1.05 | ) |
|
| Schedule of Anti-dilutive Securities Excluded from Computation of Earnings per Share |
The
following table sets forth the securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially
dilute EPS in the future:
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings per Share
| | |
2026 | | |
2025 | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| Common stock warrants | |
| 2,269,356 | | |
| 2,269,356 | |
| Common stock options and RSUs | |
| 3,095,468 | | |
| 1,740,679 | |
| Unit Purchase Options | |
| 20,182 | | |
| 20,182 | |
| Series B convertible preferred stock | |
| 11,795,724 | | |
| 13,047,642 | |
| Series C convertible preferred stock | |
| 15,533,724 | | |
| - | |
| Series D convertible preferred stock | |
| 4,831,185 | | |
| - | |
| Convertible notes | |
| 6,009,921 | | |
| 5,716,926 | |
| Total | |
| 43,555,560 | | |
| 22,794,785 | |
| Anti-dilutive securities | |
| 43,555,560 | | |
| 22,794,785 | |
|